The Preclinical Imaging Shared Facility supports multimodality imaging in preclinical models to accelerate the translation of basic research to human trials. Imaging conducted in the facility currently provides rapid, repeated, accurate, and cost-effective evaluation of new cancer treatments in preclinical models, using the most sophisticated technologies available.

The PCISF team:

  • Provides state-of-the-art molecular imaging for preclinical studies in appropriate animal models, and support IND’s for transition to human imaging studies
  • Offers consultation and training to cancer investigators for molecular imaging in cancer models
  • Establishes methods for image analyses.
  • Accurately calibrates and maintains equipment
  • Devlops novel imaging technologies

Leadership

Anna Sorace, Ph.D.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 

Technical Staff

Mark Bolding, Ph.D. MRI/MRS Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.

Hyunki Kim, Ph.D. CT Specialist
This email address is being protected from spambots. You need JavaScript enabled to view it.